MJA Vol 177 16 September 2002 S61
PATHOPHYSIOLOGY AND DIAGNOSIS Supplement
The Medical Journal of Australia ISSN: 0025-729X 16 Septem-
ber 2002 177 6 S61-S63
©The Medical Journal of Australia 2002 www.mja.com.au
Pathophysiology and diagnosis
EXERCISE-INDUCED ASTHMA (EIA) is the term used to
describe the transient reduction in lung function that occurs
after vigorous exercise.
1
A reduction in FEV
1
of 13.2% or
more after exercise is diagnostic of EIA.
2
A prevalence of
EIA of between 19.3% and 23.4% has been reported in
Australian schoolchildren.
3,4
While severity of EIA was
found to be associated with the number of wheeze attacks
per year, 40% of children identified with EIA had not been
diagnosed with asthma by a doctor.
3
Exercise is the most common stimulus for inducing an
attack in asthmatic children. Recognition of EIA is impor-
tant, because full participation in sporting activities is a goal
in the management of childhood asthma.
Failure to recognise EIA
EIA is not predicted by risk factors, including positive
answers to items about asthma in questionnaires,
5
nor is it
excluded by failure to report symptoms. In a child with
undiagnosed EIA, the enquiry that has the most potential to
elicit a positive response and thus identify EIA is “Do you
feel more breathless/wheezy/symptomatic five to ten minutes
after you stop exercise than during exercise.”
There are many reasons why EIA is not recognised.
Firstly, it occurs most commonly after exercise, so it may
not limit performance unless the child has moderate to
severe asthma. Secondly, children may fail to notice the
symptoms of EIA until they take part in organised or
competitive sport. Thirdly, 50% of children become refrac-
tory to the bronchoconstricting effects of exercise when
exercise is repeated within an hour or warm-up occurs
before exercise. This refractoriness means that the associa-
tion of exercise and “asthma” symptoms does not occur on
all occasions when exercise is performed.
EIA as a marker of airway inflammation:
the role of steroids
Most children with well-controlled asthma do not need
medication before exercise.
6
Thus, taking 400 g of budeso-
nide for 4 weeks reduced the severity of EIA to such an
extent that less than 10% of the standard dose of terbutaline
was required for complete prevention of EIA.
In a recent study of 57 children with asthma and mild EIA
(25% fall in forced expiratory volume in one second [FEV
1
]
after exercise) and a normal FEV
1
% predicted, low doses of
budesonide for 12 weeks significantly reduced the severity of
EIA (Box 1).
7
A study in children with moderate EIA (34%
fall in FEV
1
after exercise) showed that treatment with
100 g or 250 g of fluticasone for three weeks was equally
Exercise-induced asthma in children:
a marker of airway inflammation
Sandra D Anderson
Department of Respiratory Medicine, Royal Prince Alfred
Hospital, Camperdown, NSW.
Sandra D Anderson, PhD, DSc, Principal Hospital Scientist.
Correspondence: Dr Sandra D Anderson, Department of Respiratory
Medicine, Royal Prince Alfred Hospital, Missenden Road, Camperdown,
NSW 2050. sandya@mail.med.usyd.edu.au
ABSTRACT
What we know
■ Exercise-induced asthma (EIA) occurs in up to 23% of
schoolchildren.
■ In 40% of children with demonstrable EIA, no clinical
diagnosis of asthma has been made.
■ Children with asthma and EIA have eosinophils in their
sputum, consistent with active asthma.
■ EIA is well controlled in 50%–65% of children with
moderate to severe asthma, so that only a minority will
need prophylactic therapy immediately before exercise.
■
2
-Agonists are not the most suitable therapy for
preventing EIA if they need to be used on a daily basis.
■ The severity of EIA appears to be an indirect index of
the severity of airway inflammation.
What we need to know
■ Do non-symptomatic children with EIA require treatment
for asthma?
■ Does failure to identify and treat children unaware of their
airways narrowing after exercise lead to airflow limitation
in the long term, particularly in the small airways?
■ Can exercise, or surrogate tests used to identify EIA, also
be used to assess children with asthma?
■ What is the minimum dose of steroid required to inhibit
EIA, as high doses of steroids may be inappropriate in
children?
■ What is the best prophylactic treatment for EIA in children
whose asthma is otherwise well controlled by inhaled
steroids?
■ What is the best prophylactic treatment for EIA in children
with frequent episodic asthma or mild persistent asthma?
■ Are leukotriene antagonists alone better than
2
-agonists
alone in preventing EIA throughout the day?
■ How many children taking long-acting
2
-agonists twice
daily, either alone or in combination with an inhaled
steroid, experience breakthrough EIA during school and
MJA 2002; 177: S61-S63
require rescue medication?